| |
|
 |
Formulary Update
View SFHP's updated formulary.
More »
|
|
| |
|
|
Formulary
Updates from January 2011 P&T Committee for Medi-Cal, Healthy Families and Healthy
More »
|
|
| |
|
|
Updates from October 2010 P&T Committee for Medi-Cal, Healthy Families and Healthy Kids
Drug Classes Reviewed - Dermatology & Other Formulary Changes
More »
|
|
| |
|
|
Updates from July 2010 P&T Committee for Medi-Cal, Healthy Families and Healthy Kids
Smoking cessation products added to formulary with no prior authorization required!
More »
|
|
| |
|
|
Updates from April 2010
Updates from April, 2010 P&T Committee for Medi-Cal, Healthy Families and Healthy Kids
More »
|
|
| |
|
|
Formulary Updates
- Updates from January 2010 P&T Committee for Medi-Cal, Healthy Families and Healthy Kids
- Drug Class Reviewed- Ophthalmic Agents
More »
|
|
| |
|
|
Formulary Updates
- Updates from October 2009 P&T Committee for Medi-Cal, Healthy Families and Healthy Kids
- Drug Class Reviewed- ADHD Agents
More »
|
|
| |
|
|
Pharmacy Updates | Gastrointestinal Agents | H1N1 and Other Influenza Viruses
More »
|
|
| |
|
|
Formulary Options For Antiviral Treatment of H1N1 and Other Influenza Viruses
The formulary status of antiviral agents for SFHP Medi-Cal, Healthy Families and Healthy Kids programs are aligned with FDA-approved dosing and WHO Guidelines for the Treatment of H1N1 and other influenza viruses. According to the WHO Guidelines, the following high-risk populations should be considered for treatment:
More »
|
|
| |
|
|
Focus on Gastrointestinal Agents - PPI Use Linked to Increased Pneumonia, C Dificile, and Osteoporotic Fractures
PPI Use Linked to Increased Pneumonia, C Dificile, and Osteoporotic Fractures
SFHP has observed a dramatic increase in the use of PPIs over the last few years, despite data showing adverse clinical outcomes with short- and long-term PPI use (see citations below):
More »
|
|
